ExchangeDEX+

Buy Crypto Markets Spot FuturesSILVER Earn Event Center

Commodity Zero-Fee Gala

Anbio Biotechnology (NNNN)

NASDAQ

$26.05

$+2.20

(+8.00%)

Anbio Biotechnology (NNNN) Live Price Chart

Page last updated: 2026-02-27 22:49:00

Key Market Data

Market Cap	$1.14B
Open	$27.67
High	$55.65
Low	$5.18
Previous Close	$27.55
Price Change	$+2.20
Percentage Change	+8.00%
Volume	160K

Anbio Biotechnology (NNNN) Stock Price Today

Anbio Biotechnology (NNNN) is currently trading at $26.05 as of 2026-02-27 22:49:00, reflecting a +8.00% move ($+2.20) from the previous close.

In the short term, the stock has returned +114.56% over the past four weeks. Over the last 12 months, Anbio Biotechnology has recorded a +310.16% price change, indicating a strong performance relative to the broader market.

Anbio Biotechnology (NNNN) 7-Day Stock Price Changes

Over the past seven days, Anbio Biotechnology has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $25.50 to the latest recorded price of $26.05, reflecting an intraday change of +8.00%. Daily movements highlight shifts in trading volume (160,389), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, NNNN has delivered a +114.56% return over the past month and a +310.16% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Anbio Biotechnology (NNNN)

You can buy and trade NNNN on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for NNNN and Execute Your Trade

Open the trading page, enter NNNN in the search bar, select the amount of NNNN you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Anbio Biotechnology (NNNN)?

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Anbio Biotechnology Information

Industry	--
Employees	27
Sector	--
Company Website	https://www.anbio.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Anbio Biotechnology?

The latest trading price for Anbio Biotechnology (Common Stock) is $ 26.05, compared with a previous closing price of $ 27.55. That means the stock has moved +8.00% so far today. Intraday price updates and recent trading activity for NNNN can be tracked on the live chart and quote section on this page.

2.Is Anbio Biotechnology stock going up or down?

Looking at recent performances, NNNN has returned +114.56% over the past month, -42.95% over the last six months and +310.16% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Anbio Biotechnology stock, but keep in mind that past returns do not guarantee future results.

3.Where does NNNN currently sit relative to its 52-week high and low?

In the most recent 52-week period, Anbio Biotechnology has traded between a low of $ 5.89 and a high of $ 55.65. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether NNNN is currently nearer the top or the bottom of its one-year trading band.

4.How is Anbio Biotechnology classified by sector and industry?

Anbio Biotechnology is classified in the -- sector. In practice, this means Anbio Biotechnology is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing NNNN’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Anbio Biotechnology’s performance.

5.Where is Anbio Biotechnology listed and how large is it by market value?

Anbio Biotechnology is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 1.14B, the company is classified as a Small-cap stock. Market cap gives a quick sense of Anbio Biotechnology's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does NNNN's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Anbio Biotechnology has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Anbio Biotechnology's financial performance over time?

To follow Anbio Biotechnology's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how NNNN is performing and how the market is responding.

8.When is Anbio Biotechnology expected to report earnings?

Anbio Biotechnology's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for NNNN, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Anbio Biotechnology's earnings reports?

Anbio Biotechnology's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether NNNN is meeting, beating or missing expectations.

10.How can I stay informed about Anbio Biotechnology's results and guidance?

You can stay up to date on Anbio Biotechnology by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for NNNN on this page helps you see how new information is being reflected in the stock.

11.Does Anbio Biotechnology pay a regular cash dividend to its shareholders?

Anbio Biotechnology Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor NNNN's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for NNNN?

Based on the latest earnings data, NNNN has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Anbio Biotechnology is an attractive income stock. The dividend payout ratio measures what percentage of earnings Anbio Biotechnology distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Anbio Biotechnology?

Anbio Biotechnology is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is NNNN valued in terms of P/E ratio and EPS?

Anbio Biotechnology currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Anbio Biotechnology's earnings. Comparing NNNN's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Anbio Biotechnology

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

Antelope Enterprise Holdings Limited

AEHL

Applied Digital Corporation

APLD

Inflection Point Acquisition Corp. IV

BACQ

Columbia Sportswear Co

COLM

Kratos Defense & Security Solutions, Inc.

KTOS

Top Gainers

Browse today's leading gainers in the US stock market

Applied Optoelectronics, Inc.

AAOI

Avalon GloboCare Corp.

ALBT

REalloys Inc.

ALOY

Baird Medical Investment Holdings Ltd

BDMD

Brand Engagement Network Inc.

BNAI

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

MYX

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

NNNN-to-USD Calculator

Amount

NNNN

USD

1 NNNN = 26.045 USD